AVITA Medical (RCEL) Receivables - Net (2018 - 2025)
AVITA Medical (RCEL) has disclosed Receivables - Net for 5 consecutive years, with $9.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net fell 22.91% year-over-year to $9.1 million, compared with a TTM value of $9.1 million through Dec 2025, down 22.91%, and an annual FY2025 reading of $9.1 million, down 22.91% over the prior year.
- Receivables - Net was $9.1 million for Q4 2025 at AVITA Medical, up from $9.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $12.0 million in Q1 2025 and bottomed at $3.5 million in Q1 2022.
- Average Receivables - Net over 4 years is $7.3 million, with a median of $7.4 million recorded in 2023.
- The sharpest move saw Receivables - Net soared 118.04% in 2023, then fell 22.91% in 2025.
- Year by year, Receivables - Net stood at $3.5 million in 2022, then surged by 118.04% to $7.7 million in 2023, then skyrocketed by 53.78% to $11.8 million in 2024, then dropped by 22.91% to $9.1 million in 2025.
- Business Quant data shows Receivables - Net for RCEL at $9.1 million in Q4 2025, $9.0 million in Q3 2025, and $11.3 million in Q2 2025.